All Articles

AM Best's stable outlook for Korea P&I isn't just a rating change. It's a validation of a tough, calculated strategy to reduce risk and leverage state support.

A $50,000 federal grant to plan a trail network in Niisaachewan Anishinaabe Nation is more than infrastructure—it's a step towards safety and cultural revival.

SurgePays is building a powerful AI to serve 138 million subprime consumers. But as we chase innovation, we must ask: is this the path to equity or a new digital trap?

The brokerage's consistent top rankings aren't just about sales. A closer look reveals a powerful strategy blending legacy prestige with modern corporate muscle.

Most product launches fail not because of a bad product, but a flawed strategy. A new blueprint from Info-Tech Research Group reveals why and offers a fix.

Set to join the Russell 3000, Starfighters Space and its unique F-104 fleet bring Wall Street's focus to a new class of aerospace infrastructure.

Two new roadside signs honor Laura and Jamie Hannah, killed by an impaired driver. Their story is a tragic reminder of a preventable crisis on our roads.

With the approval of its advanced cancer drug Eratrectinib, Vcare PharmaTech challenges global rivals, showcasing China's AI-driven R&D and strategic ambition.

New research reveals AI is no longer just assisting IT—it's taking control. A deep dive into the shift to autonomous operations and what it means for leaders.

Guelph's new bus chargers are more than infrastructure; they represent a new era of predictable federal funding reshaping municipal finance and strategy.

With a fresh $34.5M in capital, Volatus is set to expand manufacturing and advance its defense-grade drone tech. What does this signal for the industry?

Blink Charging is selling its Envoy subsidiary to focus on core infrastructure. This isn't just a deal; it's a sign that the EV industry's era of frantic growth is giving way to a new mandate: profitability.

A new pact with Galaxy Digital lets Morgan Stanley's elite clients swap crypto for ETPs. Is this the moment Wall Street fully embraces DeFi, or a risky new frontier?

Aiper's new partnership with charity: water isn't just philanthropy. It's a calculated move to link its backyard tech to the global water crisis, turning eco-conscious consumers into brand evangelists.

Market research shows doctors are eager to prescribe Moleculin's new AML drug, Annamycin. It offers hope where there is none, but can the company survive to deliver it?

As Florida celebrates National Homeownership Month, the dream of owning a home clashes with a perfect storm of insurance crises and affordability challenges.

A new firm offers up to $250k in funded accounts for prediction market traders, a move that could professionalize a booming sector. But can it navigate the complex regulatory field?

A new lawsuit alleges a Dallas nightclub's negligent security policy allowed a patron to bypass checks for a fee, leading to a security guard's murder.

Duke Energy's $500K in grants aids first responders, but it also reveals a growing reliance on private funds as public disaster support systems face strain.

With 460,000 providers enrolled, Careviso is tackling healthcare's most hated process. A case study shows it's cutting case times by more than half.